{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:11:12Z","timestamp":1740103872632,"version":"3.37.3"},"reference-count":0,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T00:00:00Z","timestamp":1489708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01 HS022289\u201001"],"award-info":[{"award-number":["R01 HS022289\u201001"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To evaluate long\u2010term outcomes in patients undergoing either paclitaxel\u2010eluting stents (PES) or endeavor zotarolimus\u2010eluting stents (E\u2010ZES) placement and to assess comparative effectiveness of PES vs. E\u2010ZES in different \u201coff\u2010label\u201d and \u201chigh\u2010risk\u201d patient subgroups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>PES and E\u2010ZES are frequently used in percutaneous coronary interventions (PCIs). However, the long\u2010term comparative effectiveness of PES vs. E\u2010ZES in real practice is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We created a longitudinal database by linking the New York State (NYS) cardiac registries, the NYS hospital discharge file, the National Death Index, and the U.S. Census file for patients undergoing either PES or E\u2010ZES placement from July 2008 through December 2009. All\u2010cause mortality, acute myocardial infarction (AMI), target lesion PCI (TLPCI), and target vessel coronary artery bypass graft (TVCABG) surgery were compared for 9,264 propensity score matched patients for a 5\u2010year follow\u2010up period using the Kaplan\u2010Meier method with further adjustment using Cox proportional hazards regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We did not detect significant differences between E\u2010ZES and PES (reference) in 5\u2010year mortality (adjusted hazard ratio &lt;AHR&gt;: 1.02, 95% confidence interval &lt;CI&gt;: 0.91\u20131.14), AMI (AHR: 1.05, 95% CI: 0.90\u20131.22), TLPCI (AHR: 0.99, 95% CI: 0.86\u20131.13), and TVCABG (AHR, 1.07, 95% CI: 0.84\u20131.36). For six \u201coff\u2010label\u201d and two \u201chigh\u2010risk\u201d subpopulations, we had similar findings for the two stent groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NYS observational data suggest that 5\u2010year outcomes are comparable in patients receiving either PES or E\u2010ZES placement, mirroring the findings of recent clinical trials. \u00a9 2017 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.27000","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T05:52:46Z","timestamp":1489729966000},"page":"9-16","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of 5\u2010year outcomes of paclitaxel\u2010eluting and endeavor zotarolimus\u2010eluting stents in New York"],"prefix":"10.1002","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0447-8584","authenticated-orcid":false,"given":"Feng","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Health Policy Management, and Behavior, School of Public Health, University at Albany, State University of New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Health Policy Management, and Behavior, School of Public Health, University at Albany, State University of New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward L.","family":"Hannan","sequence":"additional","affiliation":[{"name":"Department of Health Policy Management, and Behavior, School of Public Health, University at Albany, State University of New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,17]]},"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.27000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.27000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T14:17:31Z","timestamp":1695910651000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.27000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1002\/ccd.27000"],"URL":"https:\/\/doi.org\/10.1002\/ccd.27000","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"type":"print","value":"1522-1946"},{"type":"electronic","value":"1522-726X"}],"subject":[],"published":{"date-parts":[[2017,3,17]]}}}